Erythroderma as a paraneoplastic manifestation of small cell lung cancer.

Autor: Zervakis SG; Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece. Electronic address: zervakis_st@hotmail.com., Spernovasilis N; Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece., Boutakoglou E; Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece., Panagiotakis S; Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece., Thomopoulou K; Department of Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece., Samonis G; Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece.
Jazyk: angličtina
Zdroj: Current problems in cancer [Curr Probl Cancer] 2020 Apr; Vol. 44 (2), pp. 100499. Date of Electronic Publication: 2019 Aug 30.
DOI: 10.1016/j.currproblcancer.2019.100499
Abstrakt: Erythroderma is a rare clinical entity characterized by generalized erythema affecting the whole or most of the body's skin surface. It is associated with a variety of underlying conditions, including preexisting dermatoses, infections, connective tissue disorders, drugs, malignancies, or it may be idiopathic. A case of a 73-year-old man, with a 5-month history of erythroderma, eventually diagnosed with small cell lung cancer is presented. This is the first reported case indicating an association between erythroderma and small cell lung cancer, extending, thus, current knowledge regarding small cell lung cancer-related paraneoplastic manifestations as well as erythroderma's causative factors.
(Copyright © 2019 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: